Irma Bagdoniene։ Why Intensive Prevention is the Most Rational Strategy in Preventive Cardiology
Irma Bagdoniene, Cardiologist Specializing in Prevention & Lipidology, shared on LinkedIn about a recent article by Jennifer G. Robinson et al, published in Journal of the American Heart Association:
”Is early, intensive prevention ‘aggressive’? It’s not. On World Logic Day, it just makes sense.
I often tell my patients:
The human body follows simple logic.
In preventive cardiology, clinical inertia is a common barrier. But the evidence to avoid delays is overwhelming. This is the basis of our ‘strike early, strike strong’ strategy:
- The logic of time: Atherosclerosis results from cumulative exposure. It’s the total LDL burden over decades—the “mg-years”—that defines risk. The sooner we act, the more years we protect.
- The logic of causality: LDL cholesterol is a proven causal factor in ASCVD. Mendelian randomization studies and large clinical trials consistently confirm this. Lowering LDL prevents downstream events.
- The logic of measurement: We cannot manage what we don’t detect. Risk scores alone fall short. Advanced assessments like CACS, CCTA, Lp(a), and ApoB provide clear evidence of subclinical disease—calling for early intervention.
The conclusion is simple. The evidence and tools are ready. Early application is the most rational approach to stopping heart attacks before they occur.
Prevention is not aggressive—it is the sensible choice.
On World Logic Day (Jan 14), proclaimed by UNESCO, a reminder:
Good medicine is often just good logic!”
Title: Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Authors: Jennifer G. Robinson, Kevin Jon Williams, Samuel Gidding, Jan Borén, Ira Tabas, Edward A. Fisher, Chris Packard, Michael Pencina, Zahi A. Fayad, Venkatesh Mani, Kerry Anne Rye, Børge G. Nordestgaard, Anne Tybjærg-Hansen, Pamela S. Douglas, Stephen J. Nicholls, Neha Pagidipati, Allan Sniderman
Read the Full Article on Journal of the American Heart Association․
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 24, 2026, 11:48Factor XII Inhibition and the Future of Contact Pathway Targeting
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
-
Sep 24, 2026, 06:08Christopher Salerno: AI-Powered At-Home Anemia Screening Advances Telehealth Access
-
Sep 24, 2026, 05:38Aya Qattan: When a Normal CBC Does Not Mean Normal Iron Status
-
Sep 24, 2026, 05:11Mastering Warm Autoimmune Hemolytic Anemia Diagnosis and Practice – ASH Education
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function